C
Eli Lilly and Company LLY
NYSE
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Revenue 28.10% 36.84% 28.11% -10.88% -8.73%
Total Other Revenue -- -- -- -- --
Total Revenue 28.10% 36.84% 28.11% -10.88% -8.73%
Cost of Revenue 15.50% 17.79% 26.35% -21.50% -27.85%
Gross Profit 31.49% 42.44% 28.61% -7.05% -1.72%
SG&A Expenses 16.73% 10.95% 18.23% 11.53% 2.03%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 20.93% 21.49% 25.94% 1.91% -8.43%
Operating Income 44.65% 73.77% 34.02% -35.61% -9.40%
Income Before Tax 19.67% -72.71% 91.48% -25.51% 13.94%
Income Tax Expenses 101.07% 325.83% 135.33% 22.63% 39.46%
Earnings from Continuing Operations 13.01% -103.95% 85.11% -29.32% 12.26%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 13.01% -103.95% 85.11% -29.32% 12.26%
EBIT 44.65% 73.77% 34.02% -35.61% -9.40%
EBITDA 38.66% 64.62% 29.18% -32.97% -10.40%
EPS Basic 13.10% -103.96% 85.24% -29.11% 12.86%
Normalized Basic EPS 45.46% 77.17% 36.49% -37.48% -10.54%
EPS Diluted 13.01% -103.96% 85.71% -29.05% 12.99%
Normalized Diluted EPS 45.46% 77.79% 36.43% -37.46% -10.54%
Average Basic Shares Outstanding -0.08% -0.10% -0.07% -0.30% -0.53%
Average Diluted Shares Outstanding -0.08% -0.44% -0.02% -0.34% -0.53%
Dividend Per Share 15.31% 15.31% 15.31% 15.31% 15.29%
Payout Ratio 0.02% -30.13% -0.38% 0.63% 0.02%
Weiss Ratings